Shimpei Iikuni
Kyoto, 6068501, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Synthesis and Evaluation of 18F-Labeled Chalcone Analogue for Detection of α-Synuclein Aggregates in the Brain Using the Mouse Model.
Journal: ACS chemical neuroscience
Published: October 05, 2022
Application of the Chelator-Based Clickable Radiotheranostic Platform to Moderate-Molecular-Weight Ligands.
Journal: ACS medicinal chemistry letters
Published: July 11, 2022
Structure-Activity Relationships and Pharmacokinetics of 111In-Labeled Glucagon-like Peptide-1 Receptor-Targeting Exendin-4 Derivatives Conjugated with Albumin Binder Moieties.
Journal: Molecular pharmaceutics
Published: June 27, 2022
Synthesis and Evaluation of Novel 111In-Labeled Picolinic Acid-Based Radioligands Containing an Albumin Binder for Development of a Radiotheranostic Platform.
Journal: Molecular pharmaceutics
Published: June 27, 2022
Development of an 111In-Labeled Glucagon-Like Peptide-1 Receptor-Targeting Exendin-4 Derivative that Exhibits Reduced Renal Uptake.
Journal: Molecular pharmaceutics
Published: February 09, 2022
Synthesis and evaluation of novel radioiodinated phenylbenzofuranone derivatives as α-synuclein imaging probes.
Journal: Bioorganic & medicinal chemistry letters
Published: February 02, 2022
Characterization of Radioiodinated Diaryl Oxadiazole Derivatives as SPECT Probes for Detection of Myelin in Multiple Sclerosis.
Journal: ACS chemical neuroscience
Published: January 12, 2022
Chalcone Analogue as New Candidate for Selective Detection of α-Synuclein Pathology.
Journal: ACS chemical neuroscience
Published: December 15, 2021
Development of novel 67/68Ga-labeled pyridyl benzofuran derivatives as islet amyloid imaging probes.
Development of novel 67/68Ga-labeled pyridyl benzofuran derivatives as islet amyloid imaging probes.
Journal: Nuclear medicine and biology
Published: October 14, 2021
Radiotheranostics Using a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen.
Journal: Journal of medicinal chemistry
Published: September 03, 2021
Feasibility of using a 99mTc-hydroxamamide complex containing an albumin binder moiety for in vivo albumin labeling-based tumor imaging.
Journal: Bioorganic & medicinal chemistry letters
Published: August 22, 2021
Last Updated: 09/26/2026